We are live on ! Find out more
CWG

C WorldWide Group Portfolio holdings

AUM $4.66B
1-Year Est. Return 11.67%
This Fund
S&P 500
This Quarter Est. Return
+11.54%
1 Year Est. Return
+11.67%
3 Year Est. Return
+62.16%
5 Year Est. Return
+69.96%
10 Year Est. Return
+372.2%
AUM
$5.91B
AUM Growth
+$723M
Cap. Flow
+$207M
Cap. Flow %
3.5%
Top 10 Hldgs %
67.97%
Holding
140
New
16
Increased
56
Reduced
33
Closed
12

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$271M
2
BKNG icon
Booking.com
BKNG
+$175M
3
PM icon
Philip Morris
PM
+$130M
4
V icon
Visa
V
+$66.6M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$41.3M

Top Sells

Rank Stock Value
1
RAI
Reynolds American Inc
RAI
+$279M
2
BBWI icon
Bath & Body Works
BBWI
+$245M
3
CVS icon
CVS Health
CVS
+$244M
4
TSM icon
TSMC
TSM
+$6.36M
5
DVA icon
DaVita
DVA
+$6.35M

Sector Composition

Rank Sector Weight
1 Financials 27.75%
2 Healthcare 19.16%
3 Consumer Discretionary 17.5%
4 Communication Services 14.74%
5 Materials 7.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EGRX
51
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$5.4M 0.09%
65,085
+11,485
+21% +$854K
ABBV icon
52
AbbVie
ABBV
$465B
$5.27M 0.09%
80,825
– –
HZNP
53
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$4.89M 0.08%
330,709
+47,069
+17% +$762K
PTLA
54
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$4.88M 0.08%
124,553
+10,373
+9% +$330K
KITE
55
DELISTED
Kite Pharma, Inc.
KITE
$4.8M 0.08%
61,100
-2,804
-4% -$173K
ALXN
56
DELISTED
Alexion Pharmaceuticals
ALXN
$4.7M 0.08%
38,751
+87
+0.2% +$11.2K
ESRX
57
DELISTED
Express Scripts Holding Company
ESRX
$4.58M 0.08%
69,495
– –
EXAS
58
DELISTED
Exact Sciences
EXAS
$4.51M 0.08%
191,154
+16,154
+9% +$320K
DXCM icon
59
DexCom
DXCM
$29B
$4.34M 0.07%
204,976
+19,276
+10% +$376K
SUPN icon
60
Supernus Pharmaceuticals
SUPN
$2.7B
$4.26M 0.07%
136,272
+33,272
+32% +$892K
AIMT
61
DELISTED
Aimmune Therapeutics
AIMT
$4.09M 0.07%
+188,100
New +$3.86M
CHRS icon
62
Coherus Oncology
CHRS
$217M
$4.08M 0.07%
192,887
+98,211
+104% +$2.42M
RARE icon
63
Ultragenyx Pharmaceutical
RARE
$2.46B
$3.98M 0.07%
58,670
+4,445
+8% +$339K
TVRD
64
Tvardi Therapeutics
TVRD
$20.1M
$3.95M 0.07%
5,961
-2,923
-33% -$1.56M
NVDQ
65
DELISTED
Novadaq Technologies Inc.
NVDQ
$3.86M 0.07%
495,972
+185,972
+60% +$1.32M
PODD icon
66
Insulet
PODD
$11.8B
$3.85M 0.07%
89,421
-28,579
-24% -$1.23M
ELGX
67
DELISTED
Endologix Inc
ELGX
$3.8M 0.06%
52,456
+15,456
+42% +$1.02M
KTWO
68
DELISTED
K2M Group Holdings, Inc
KTWO
$3.58M 0.06%
174,371
+84,371
+94% +$1.73M
AERI
69
DELISTED
Aerie Pharmaceuticals
AERI
$3.45M 0.06%
76,091
+4,008
+6% +$179K
AQN icon
70
Algonquin Power & Utilities
AQN
$4.59B
$3.35M 0.06%
+264,000
New +$2.38M
MA icon
71
Mastercard
MA
$498B
$3.18M 0.05%
28,300
– –
XENT
72
DELISTED
Intersect ENT, Inc
XENT
$3.11M 0.05%
181,550
+16,550
+10% +$232K
ITCI
73
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$3.05M 0.05%
187,823
+91,775
+96% +$1.33M
AIRM
74
DELISTED
Air Methods Corp
AIRM
$3.01M 0.05%
70,000
-41,000
-37% -$1.58M
ZBH icon
75
Zimmer Biomet
ZBH
$18.8B
$2.91M 0.05%
24,561
-28,224
-53% -$3.2M
1 2
3
4 5

Similar funds

ASC
Atalanta Sosnoff Capital New York $4.66B AUM 41.34% 1-Year Est. Return
MA
Mutual Advisors Omaha, Nebraska $4.67B AUM 17.48% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
EI
EFG International Zurich $4.67B AUM
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $4.64B AUM 38.78% 1-Year Est. Return
LPPI
Local Pensions Partnership Investment London, United Kingdom $4.63B AUM 13.51% 1-Year Est. Return
CCWM
Cassaday & Co Wealth Management Mclean, Virginia $4.69B AUM 20.56% 1-Year Est. Return

C WorldWide Group's Q1 2017 Portfolio in Review

As of Q1 2017, C WorldWide Group held 140 positions worth $5.91B, up 14% from $5.18B the previous quarter. Its ten largest holdings account for 68% of the portfolio.

C WorldWide Group deployed $207M of net new capital in Q1 2017, opening 16 new positions and adding to 56 existing holdings. Its largest new stake was Booking.com: 2,659,100 shares worth $189M.

By sector, the portfolio is most concentrated in Financials at 28% of assets, up from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Reynolds American Inc, an estimated $279M trimmed.

  • C WorldWide Group's largest Q1 2017 buy was Booking.com: 2,659,100 shares worth $189M.
  • C WorldWide Group added most to Thermo Fisher Scientific in Q1 2017, an estimated $271M increase.
  • C WorldWide Group's biggest Q1 2017 reduction was Reynolds American Inc, cutting an estimated $279M.
  • C WorldWide Group fully exited Bath & Body Works in Q1 2017, selling an estimated $245M.
  • C WorldWide Group's ten largest holdings make up 68% of its $5.91B portfolio in Q1 2017.
  • C WorldWide Group opened 16 new positions and closed 12 in Q1 2017.
  • C WorldWide Group's portfolio value rose 14% quarter-over-quarter to $5.91B.

Based on C WorldWide Group's 13F filing for Q1 2017, filed 1 May 2017.